Pharmacotherapy preceding monocyte harvest interferes with the potency of monocyte-derived dendritic cell anticancer vaccine
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F19%3A00112779" target="_blank" >RIV/00216224:14110/19:00112779 - isvavai.cz</a>
Result on the web
<a href="https://www.annalsofoncology.org/article/S0923-7534(20)34420-3/abstract" target="_blank" >https://www.annalsofoncology.org/article/S0923-7534(20)34420-3/abstract</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1093/annonc/mdz448.006" target="_blank" >10.1093/annonc/mdz448.006</a>
Alternative languages
Result language
angličtina
Original language name
Pharmacotherapy preceding monocyte harvest interferes with the potency of monocyte-derived dendritic cell anticancer vaccine
Original language description
Refractory and relapsing sarcoma and high-risk neuroblastoma show poor prognoses. Monocyte-derived dendritic cell anticancer vaccine could extend the treatment modalities in these patients. Pharmacotherapy prior to mononuclear cell harvest may influence the quality of manufactured dendritic cell product.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
<a href="/en/project/LM2015090" target="_blank" >LM2015090: Czech National Node to the European Clinical Research Infrastructure Network</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů